KATEE POPE: Open Payments
NPI 1215344650 · HOLLAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,163 in 53 payments from 15 companies in 2025. Trend: 2023 $1,057 · 2024 $1,070 · 2025 $1,163
Food & beverage: $1,068Education: $94
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $251 |
| ABBVIE INC. | 13 | $211 |
| Janssen Biotech, Inc. | 5 | $201 |
| Lilly USA, LLC | 2 | $139 |
| Madrigal Pharmaceuticals | 1 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $71 |
| GENZYME CORPORATION | 2 | $35 |
| PFIZER INC. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
Products named: XIFAXAN, TREMFYA, OMVOH, REZDIFFRA, RINVOQ, ENTYVIO, SKYRIZI, DUPIXENT.
Industry payments across MI — which companies pay providers there.
